Johnson E, Corrick S, Isley S, Vandermeer B, Dolgoy N, Bates J
PLOS Digit Health. 2024; 3(1):e0000435.
PMID: 38261600
PMC: 10805319.
DOI: 10.1371/journal.pdig.0000435.
DSilva A, Islam Z, Marshall D, Vallance J, Nasser Y, Rajagopalan V
Dig Dis Sci. 2023; 69(1):169-179.
PMID: 37914888
DOI: 10.1007/s10620-023-08125-7.
Coates M, Clarke K, Williams E, Jeganathan N, Yadav S, Giampetro D
Crohns Colitis 360. 2023; 5(4):otad055.
PMID: 37867930
PMC: 10588456.
DOI: 10.1093/crocol/otad055.
Mayeli A, Al Zoubi O, White E, Chappelle S, Kuplicki R, Morton A
Nat Commun. 2023; 14(1):3398.
PMID: 37311748
PMC: 10264354.
DOI: 10.1038/s41467-023-39058-4.
Weeks I, Abber S, Thomas J, Calabrese S, Kuo B, Staller K
J Clin Gastroenterol. 2023; 57(7):651-662.
PMID: 37079861
PMC: 10623385.
DOI: 10.1097/MCG.0000000000001853.
Psychological Features in the Inflammatory Bowel Disease-Irritable Bowel Syndrome Overlap: Developing a Preliminary Understanding of Cognitive and Behavioral Factors.
Petrik M, Palmer B, Khoruts A, Vaughn B
Crohns Colitis 360. 2023; 3(3):otab061.
PMID: 36776665
PMC: 9802046.
DOI: 10.1093/crocol/otab061.
Development of a brief cognitive-behavioral treatment for avoidant/restrictive food intake disorder in the context of disorders of gut-brain interaction: Initial feasibility, acceptability, and clinical outcomes.
Murray H, Weeks I, Becker K, Ljotsson B, Madva E, Eddy K
Int J Eat Disord. 2022; 56(3):616-627.
PMID: 36550697
PMC: 9992156.
DOI: 10.1002/eat.23874.
Review article: exclude or expose? The paradox of conceptually opposite treatments for irritable bowel syndrome.
Biesiekierski J, Manning L, Murray H, Vlaeyen J, Ljotsson B, Van Oudenhove L
Aliment Pharmacol Ther. 2022; 56(4):592-605.
PMID: 35775328
PMC: 11327802.
DOI: 10.1111/apt.17111.
Internet-Delivered Cognitive Behavioral Therapy in Patients With Irritable Bowel Syndrome: Systematic Review and Meta-Analysis.
Kim H, Oh Y, Chang S
J Med Internet Res. 2022; 24(6):e35260.
PMID: 35687389
PMC: 9233255.
DOI: 10.2196/35260.
Meditation and yoga for irritable bowel syndrome: study protocol for a randomised clinical trial (MY-IBS study).
DSilva A, Marshall D, Vallance J, Nasser Y, Rajagopalan V, MacKean G
BMJ Open. 2022; 12(5):e059604.
PMID: 35618329
PMC: 9137346.
DOI: 10.1136/bmjopen-2021-059604.
Acceptability and efficacy of the Zemedy app versus a relaxation training and meditation app for IBS: protocol for a randomised controlled trial.
Hunt M, Dalvie A, Ipek S, Wasman B
BMJ Open. 2022; 12(1):e055014.
PMID: 35039299
PMC: 8765021.
DOI: 10.1136/bmjopen-2021-055014.
Assessing the post-treatment therapeutic effect of pinaverium in irritable bowel syndrome: a randomized controlled trial.
Zheng L, Lu W, Xiao Q, Lai Y, Fan H, Sun Y
Sci Rep. 2021; 11(1):13894.
PMID: 34230526
PMC: 8260803.
DOI: 10.1038/s41598-021-92990-7.
Specific and common mediators of gastrointestinal symptom improvement in patients undergoing education/support vs. cognitive behavioral therapy for irritable bowel syndrome.
Lackner J, Jaccard J
J Consult Clin Psychol. 2021; 89(5):435-453.
PMID: 34124927
PMC: 9380705.
DOI: 10.1037/ccp0000648.
Preliminary investigation of the associations between psychological flexibility, symptoms and daily functioning in people with chronic abdominal pain.
Yu L, Inspector Y, McCracken L
Br J Pain. 2021; 15(2):175-186.
PMID: 34055339
PMC: 8138614.
DOI: 10.1177/2049463720926559.
Efficacy of Zemedy, a Mobile Digital Therapeutic for the Self-management of Irritable Bowel Syndrome: Crossover Randomized Controlled Trial.
Hunt M, Miguez S, Dukas B, Onwude O, White S
JMIR Mhealth Uhealth. 2021; 9(5):e26152.
PMID: 33872182
PMC: 8176342.
DOI: 10.2196/26152.
Patients' Experiences of Telephone-Based and Web-Based Cognitive Behavioral Therapy for Irritable Bowel Syndrome: Longitudinal Qualitative Study.
Hughes S, Sibelli A, Everitt H, Moss-Morris R, Chalder T, Harvey J
J Med Internet Res. 2020; 22(11):e18691.
PMID: 33216002
PMC: 7718092.
DOI: 10.2196/18691.
Potential Benefit With Complementary and Alternative Medicine in Irritable Bowel Syndrome: A Systematic Review and Meta-analysis.
Billings W, Mathur K, Craven H, Xu H, Shin A
Clin Gastroenterol Hepatol. 2020; 19(8):1538-1553.e14.
PMID: 32961342
PMC: 8112831.
DOI: 10.1016/j.cgh.2020.09.035.
Discriminant and convergent validity of the GSRS-IBS symptom severity measure for irritable bowel syndrome: A population study.
Ljotsson B, Jones M, Talley N, Kjellstrom L, Agreus L, Andreasson A
United European Gastroenterol J. 2020; 8(3):284-292.
PMID: 32213021
PMC: 7184654.
DOI: 10.1177/2050640619900577.
Treating irritable bowel syndrome through an interdisciplinary approach.
Nelkowska D
Ann Gastroenterol. 2020; 33(1):1-8.
PMID: 31892791
PMC: 6928481.
DOI: 10.20524/aog.2019.0441.
Cognitive behavioral therapy with interoceptive exposure and complementary video materials for irritable bowel syndrome (IBS): protocol for a multicenter randomized controlled trial in Japan.
Kawanishi H, Sekiguchi A, Funaba M, Fujii Y, Yoshiuchi K, Kikuchi H
Biopsychosoc Med. 2019; 13:14.
PMID: 31178921
PMC: 6551860.
DOI: 10.1186/s13030-019-0155-2.